Selby Peter, Popescu Razvan, Lawler Mark, Butcher Hugh, Costa Alberto
1 Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
2 Hirslanden Klinik Aarau, Aarau, Switzerland.
Am Soc Clin Oncol Educ Book. 2019 Jan;39:332-340. doi: 10.1200/EDBK_236857. Epub 2019 May 17.
Multidisciplinary teams (MDTs) have been recommended as a key part of best cancer care for 25 years. Here, we set out the functions and approaches of MDTs and review their impact. Although the literature is patchy in quality, MDTs contribute to improving cancer care and outcomes. They must be well organized, efficient, and well led; work with sound and timely information; and communicate well within the team and with their patients. Patients need carefully prepared information to help them share in the decision-making process. MDTs will be improved by a series of ongoing innovative developments. Increasing information from molecular pathology will increase the precision of their decisions, although the technologies remain expensive and may not be accessible in all countries for some time. New point-of-care testing technologies will improve the quality and timeliness of testing. Good informatics is essential to deliver the information to patients and the MDT. MDTs should be research active, delivering clinical trials, and this should improve outcomes for all of their patients. Patient engagement and empowerment in MDTs should improve patient satisfaction and outcomes. Patient-reported outcome measures will improve MDTs' insights into their patients' problems and symptoms and can improve patient outcomes.
25年来，多学科团队（MDTs）一直被推荐为优质癌症护理的关键组成部分。在此，我们阐述多学科团队的功能和方法，并回顾其影响。尽管文献质量参差不齐，但多学科团队有助于改善癌症护理和治疗结果。它们必须组织良好、高效且领导得力；依据准确及时的信息开展工作；团队内部以及与患者之间要进行良好沟通。患者需要精心准备的信息来帮助他们参与决策过程。一系列持续的创新发展将提升多学科团队。来自分子病理学的信息不断增加，将提高其决策的精准度，尽管这些技术仍然昂贵，且在一段时间内并非所有国家都能获取。新的即时检验技术将提高检测的质量和及时性。良好的信息学对于向患者和多学科团队提供信息至关重要。多学科团队应积极开展研究，进行临床试验，这应能改善所有患者的治疗结果。患者在多学科团队中的参与和赋权应能提高患者满意度和治疗结果。患者报告的结局指标将增进多学科团队对患者问题和症状的了解，并可改善患者治疗结果。
